中藥制造行業知名品牌,隸屬于中恒集團,集種植、生產、銷售、研發于一體的現代化綜合型制藥企業,涵蓋中華/晨鐘/中恒等品牌
廣(guang)西梧(wu)州制(zhi)(zhi)藥(yao)(yao)(集團(tuan)(tuan))股份有限(xian)公司(si)(簡稱梧(wu)州制(zhi)(zhi)藥(yao)(yao)),是上市公司(si)中恒集團(tuan)(tuan)(股票(piao)代(dai)碼:600252)的(de)下屬企業,系出嶺(ling)南中藥(yao)(yao)之鄉。嶺(ling)南中藥(yao)(yao),歷史悠久(jiu),名揚中華(hua),民族(zu)瑰寶。梧(wu)州制(zhi)(zhi)藥(yao)(yao)在近90年的(de)發展歷史中,已成(cheng)為集種植、生(sheng)產、銷售(shou)、研發于(yu)一體(ti)的(de)現代(dai)化綜合型制(zhi)(zhi)藥(yao)(yao)企業,是國家高新技術企業。
梧州制(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)資源豐(feng)富,擁(yong)有化(hua)學原料藥(yao)(yao)(yao)(yao)(yao)(yao)、中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)注射劑(ji)等(deng)14個(ge)(ge)(ge)(ge)(ge)大類劑(ji)型217個(ge)(ge)(ge)(ge)(ge)品(pin)(pin)(pin)種(其中(zhong)(zhong)(zhong)中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)制(zhi)劑(ji)135個(ge)(ge)(ge)(ge)(ge),化(hua)學藥(yao)(yao)(yao)(yao)(yao)(yao)82個(ge)(ge)(ge)(ge)(ge)),擁(yong)有藥(yao)(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)注冊證309個(ge)(ge)(ge)(ge)(ge),獲國(guo)家(jia)專利55個(ge)(ge)(ge)(ge)(ge),全(quan)國(guo)獨有生產品(pin)(pin)(pin)種24個(ge)(ge)(ge)(ge)(ge),《中(zhong)(zhong)(zhong)國(guo)藥(yao)(yao)(yao)(yao)(yao)(yao)典》收載品(pin)(pin)(pin)種105個(ge)(ge)(ge)(ge)(ge),國(guo)家(jia)中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)保護品(pin)(pin)(pin)種5個(ge)(ge)(ge)(ge)(ge),國(guo)家(jia)醫保目錄品(pin)(pin)(pin)種86個(ge)(ge)(ge)(ge)(ge)(其中(zhong)(zhong)(zhong)中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)種54個(ge)(ge)(ge)(ge)(ge),西藥(yao)(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)種32個(ge)(ge)(ge)(ge)(ge))國(guo)家(jia)基本藥(yao)(yao)(yao)(yao)(yao)(yao)物(wu)目錄品(pin)(pin)(pin)種45個(ge)(ge)(ge)(ge)(ge)(其中(zhong)(zhong)(zhong)中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)種31個(ge)(ge)(ge)(ge)(ge),化(hua)學藥(yao)(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)及生物(wu)制(zhi)品(pin)(pin)(pin)14個(ge)(ge)(ge)(ge)(ge)),以及“中(zhong)(zhong)(zhong)華”、“晨鐘”和“中(zhong)(zhong)(zhong)恒”等(deng)品(pin)(pin)(pin)牌,擁(yong)有注射用血栓通(tong)、婦炎(yan)凈膠(jiao)囊(nang)、中(zhong)(zhong)(zhong)華跌打丸、結石通(tong)片等(deng)主導產品(pin)(pin)(pin)。在發展過(guo)程中(zhong)(zhong)(zhong),梧州制(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)視產品(pin)(pin)(pin)質(zhi)量(liang)(liang)為企業的(de)生命和患者的(de)生命,嚴格按(an)照GMP要求,不斷完善質(zhi)量(liang)(liang)管(guan)理體系(xi)和檢測手段,加(jia)強質(zhi)量(liang)(liang)全(quan)程監管(guan),保障藥(yao)(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)質(zhi)量(liang)(liang)安全(quan)。
梧州制藥(yao)大力實施“產(chan)業(ye)(ye)興國,科(ke)技(ji)強企(qi)”的創新(xin)(xin)戰(zhan)略,以(yi)資金為保障,以(yi)人才(cai)為依托,以(yi)科(ke)技(ji)為動(dong)力,以(yi)市(shi)場為導向,以(yi)效益為中心,以(yi)發(fa)展為目標,充(chong)分發(fa)揮自(zi)身技(ji)術人才(cai)和(he)技(ji)術平臺(tai)優勢,推動(dong)自(zi)主創新(xin)(xin)驅動(dong),加(jia)強對中藥(yao)前沿(yan)技(ji)術、新(xin)(xin)工(gong)藝、新(xin)(xin)產(chan)品(pin)的研發(fa),以(yi)及老產(chan)品(pin)的二次開發(fa),促(cu)進產(chan)品(pin)結構和(he)產(chan)業(ye)(ye)升級,增強產(chan)品(pin)的市(shi)場競(jing)爭(zheng)(zheng)力、產(chan)業(ye)(ye)的發(fa)展競(jing)爭(zheng)(zheng)力和(he)企(qi)業(ye)(ye)的核心競(jing)爭(zheng)(zheng)力。
梧(wu)州制藥(yao)是我國(guo)(guo)中(zhong)(zhong)(zhong)藥(yao)制造(zao)前端的(de)(de)(de)(de)一顆璀璨明珠,專(zhuan)注于研(yan)制造(zao)福眾生的(de)(de)(de)(de)純正好藥(yao)。“十三五”期間,將圍繞醫(yi)(yi)藥(yao)健康(kang)(kang)(kang)(kang)領域的(de)(de)(de)(de)傳(chuan)承與創(chuang)新,以中(zhong)(zhong)(zhong)藥(yao)產(chan)業(ye)鏈(lian)為(wei)主體,以消(xiao)費者(zhe)健康(kang)(kang)(kang)(kang)為(wei)延伸,以特色化(hua)學藥(yao)為(wei)補充(chong),抓住國(guo)(guo)家“十三五”建成(cheng)小(xiao)康(kang)(kang)(kang)(kang)社(she)會和落實“健康(kang)(kang)(kang)(kang)中(zhong)(zhong)(zhong)國(guo)(guo)”的(de)(de)(de)(de)戰略規劃的(de)(de)(de)(de)時機,以國(guo)(guo)家大(da)(da)力促(cu)進中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)事業(ye)發(fa)展(zhan)、大(da)(da)力推動醫(yi)(yi)藥(yao)科技創(chuang)新、大(da)(da)力發(fa)展(zhan)健康(kang)(kang)(kang)(kang)服務業(ye)為(wei)契機,利用廣(guang)(guang)西地方(fang)政府大(da)(da)力推進中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)壯(zhuang)瑤醫(yi)(yi)藥(yao)現代(dai)化(hua)的(de)(de)(de)(de)機遇,結合公(gong)司的(de)(de)(de)(de)市場與資源(yuan)(yuan)優勢,努力成(cheng)為(wei)廣(guang)(guang)西醫(yi)(yi)藥(yao)健康(kang)(kang)(kang)(kang)資源(yuan)(yuan)的(de)(de)(de)(de)整合者(zhe),定位于打造(zao)兩廣(guang)(guang)區(qu)域、國(guo)(guo)內(nei)有影響力的(de)(de)(de)(de)醫(yi)(yi)藥(yao)產(chan)業(ye)綜合企業(ye)。